Welcome to the Cannabis Countdown. Right now, they will recap and commencement the best 10 cannabis stock reports for the seven day stretch of January twentieth – 26th, 2020.

Right away, they should begin.

10. 4 North American Pot Stocks With New ‘Purchase’ Ratings and Price Targets

New Ratings Released By Echelon Wealth Partners, Beacon Securities, M Partners and Clarus Securities

It’s been a bustling week in the cannabis part as four unique examiners have started inclusion or discharged research reports on 2 U.S. Multi-State Operators (MSO) just as 2 Canadian Licensed Producers (LP). Every one of the four Cannabis Stocks got ‘Purchase’ evaluations and bullish value targets.

9. TSX and S&P Launch New Cannabis Indices, Here’s the Full List of Constituents From Each Index

We should Take a Look at the Constituents That Make Up of Both Cannabis Indices

The new cannabis lists discharged by Dow Jones Indices and the TMX Group, which possesses and works the Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) highlights a blend of Canadian and global Pot Stocks. Here is the full rundown of constituents that make up both cannabis files.

8. Dan Bilzerian’s Ignite International Expands Product Line Forming New IGNITE Beverages Division

Touch off to Launch a Variety of Ready-to-Drink Beverages Featuring a Branded Alkaline PH9 Water

Touch off International Brands (CSE: BILZ) (OTCQX: BILZF) (FRA: 2L0) reported that the organization is extending its item contributions with the development of another business division called IGNITE Beverages. BILZ stock took off over 12% the day of the drink declaration which may have catalyzed an inversion in the stock.

7. Breaking down Medmen CEO Adam Bierman’s Response To Market Rumors

For Those Focused on the Cannabis Sector, You’re Likely Aware of the Recent Drama with MedMen

Various sources have shown that providers of MedMen (CSE: MMEN) (OTCQX: MMNNF) (FRA: 0JS) have not been paid and that the organization is right now renegotiating with sellers to diminish payables. Internet based life has been clamoring to find a good pace of things with one media firm distributing a Q&A with MedMen CEO Adam Bierman to talk about the gossipy tidbits.

6. Is Aurora Cannabis the Titanic of Marijuana Stocks?

Some Think ACB is Headed for an Epic Disaster, Here’s Where They’re Right and Where They’re Wrong

Contrasting certain Pot Stocks with a ship likely isn’t the best similarity. Be that as it may, They couldn’t resist thinking about the Titanic subsequent to seeing a portion of the features in the course of the most recent few months about Aurora Cannabis (TSX: ACB) (NYSE: ACB) (FRA: 21P). For instance, in December an examiner set a put a $0 value focus on ACB stock value focus on ACB stock. Financial specialists couldn’t be accused in the event that they have a sinking feeling. Be that as it may, is Aurora Cannabis actually the Titanic of Marijuana Stocks?

5. Which Cannabis ETF is the Best?

Considering How to Play the Marijuana Sector? Attempt an ETF

Pondering which Cannabis ETF is the best? This expert says pick Evolve Marijuana ETF (TSX: SEED) over Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ).

4. Aphria Receives EU GMP Certification, New Analyst Initiates Coverage, Places Bullish Price Target on APHA

Aphria Can Now Sell Medical Cannabis Throughout the EU with first Shipments to Germany Expected in Q4

Aphria (TSX: APHA) (NYSE: APHA) (FRA: 10E) reported that the organization has verified its European Union Good Manufacturing Practices accreditation otherwise called EU GMP affirmation for its backup, ARA – Avanti Rx Analytics. APHA’s bullish stock outline is prepared for a breakout after Alliance Global gave another Buy rating and value target.

3. Red White and Bloom Closes USD Million Non-Dilutive Financing

No Warrants or Conversion Equity Rights Were Connected to RWB’s Financing

Red White and Bloom (RWB) shut on its new obligation office with a solitary organization with $50 million subsidized to RWB on the end date. Before this venture, the organization had raised over USD $90 million to support its speculations and tasks in Michigan, Massachusetts and Illinois.

2. American Cannabis Stocks Are Working Their Way to Wall Street

7 Years Ago There Were Very Few Publicly Traded Cannabis Companies, None of Them on Major Exchanges

Today, in excess of twelve Cannabis Stocks exchange on significant trades, however not many of them are working in the United States. Rather, most by far of the Pot Stocks on the NYSE or NASDAQ work in Canada, where cannabis is governmentally lawful, however this is beginning to change.

1. Aphria Secures second EU GMP Certification, APHA Stock Surges 8% Confirming Breakout and Trend Reversal

Aphria Announces Back to Back EU GMP Certifications, This Time for Aphria One

Aphria (TSX: APHA) (NYSE: APHA) (FRA: 10E) reported that the organization has gotten per second EU GMP confirmation, this time for its Aphria One office in Leamington, Ontario. This news filled in as the impetus for APHA’s bullish specialized breakout.